TELA Bio’s management is scheduled to present virtually at the H.C. Wainwright Annual
TELA Bio’s management will also be participating in the
About
Investor Contact
332-895-3230
ir@telabio.com
Source:
2022 GlobeNewswire, Inc., source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.39 USD | -1.35% | -14.76% | -33.69% |
Apr. 15 | TELA Bio, Inc. Announces U.S. Commercial Launch of Robotic-Compatible OviTex IHR | CI |
Mar. 22 | Piper Sandler Adjusts Price Target on TELA Bio to $12 From $15, Maintains Overweight Rating | MT |
TELA Bio’s management is scheduled to present virtually at the H.C. Wainwright Annual
TELA Bio’s management will also be participating in the
About
Investor Contact
332-895-3230
ir@telabio.com
Source:
2022 GlobeNewswire, Inc., source
1st Jan change | Capi. | |
---|---|---|
-33.69% | 110M | |
-2.92% | 185B | |
-3.80% | 107B | |
-5.48% | 67.55B | |
+11.22% | 54.6B | |
+16.74% | 47.42B | |
+2.47% | 42.24B | |
+4.56% | 28.24B | |
+1.64% | 26.42B | |
+11.58% | 25.66B |